Department of Radiology and Research Institute of Radiological Science and Center for Clinical Imaging Data Science, Yonsei University College of Medicine, Seoul, Republic of Korea.
Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Eur J Radiol. 2024 Apr;173:111384. doi: 10.1016/j.ejrad.2024.111384. Epub 2024 Feb 18.
To compare the clinical, qualitative and quantitative imaging phenotypes, including tumor oxygenation characteristics of midline-located IDH-wildtype glioblastomas (GBMs) and H3 K27-altered diffuse midline gliomas (DMGs) in adults.
Preoperative MRI data of 55 adult patients with midline-located IDH-wildtype GBM or H3 K27-altered DMG (32 IDH-wildtype GBM and 23 H3 K27-altered DMG patients) were included. Qualitative imaging assessment was performed. Quantitative imaging assessment including the tumor volume, normalized cerebral blood volume, capillary transit time heterogeneity (CTH), oxygen extraction fraction (OEF), relative cerebral metabolic rate of oxygen values, and mean ADC value were performed from the tumor mask via automatic segmentation. Univariable and multivariable logistic analyses were performed.
On multivariable analysis, age (odds ratio [OR] = 0.92, P = 0.015), thalamus or medulla location (OR = 10.48, P = 0.013), presence of necrosis (OR = 0.15, P = 0.038), and OEF (OR = 0.01, P = 0.042) were independent predictors to differentiate H3 K27-altered DMG from midline-located IDH-wildtype GBM. The area under the curve, accuracy, sensitivity, and specificity of the multivariable model were 0.88 (95 % confidence interval: 0.77-0.95), 81.8 %, 82.6 %, and 81.3 %, respectively.
Along with younger age, tumor location, less frequent necrosis, and lower OEF may be useful imaging biomarkers to differentiate H3 K27-altered DMG from midline-located IDH-wildtype GBM. Tumor oxygenation imaging biomarkers may reflect the less hypoxic nature of H3 K27-altered DMG than IDH-wildtype GBM and may contribute to differentiation.
比较中线部位 IDH 野生型胶质母细胞瘤(GBM)和 H3 K27 改变弥漫性中线胶质瘤(DMG)的临床、定性和定量成像表型,包括肿瘤氧合特征。
纳入 55 例中线部位 IDH 野生型 GBM 或 H3 K27 改变 DMG 成人患者的术前 MRI 数据(32 例 IDH 野生型 GBM 和 23 例 H3 K27 改变 DMG 患者)。进行定性成像评估。通过自动分割从肿瘤掩模进行定量成像评估,包括肿瘤体积、归一化脑血容量、毛细血管渡越时间异质性(CTH)、氧摄取分数(OEF)、相对脑氧代谢率值和平均 ADC 值。进行单变量和多变量逻辑分析。
多变量分析显示,年龄(比值比 [OR] = 0.92,P = 0.015)、丘脑或延髓位置(OR = 10.48,P = 0.013)、坏死存在(OR = 0.15,P = 0.038)和 OEF(OR = 0.01,P = 0.042)是区分 H3 K27 改变 DMG 与中线部位 IDH 野生型 GBM 的独立预测因子。多变量模型的曲线下面积、准确性、敏感度和特异度分别为 0.88(95%置信区间:0.77-0.95)、81.8%、82.6%和 81.3%。
除了年龄较小外,肿瘤位置、较少发生坏死和较低的 OEF 可能是区分 H3 K27 改变 DMG 与中线部位 IDH 野生型 GBM 的有用成像生物标志物。肿瘤氧合成像生物标志物可能反映了 H3 K27 改变 DMG 比 IDH 野生型 GBM 的缺氧程度较低,可能有助于区分。